DE69522589T2 - Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung - Google Patents

Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung

Info

Publication number
DE69522589T2
DE69522589T2 DE69522589T DE69522589T DE69522589T2 DE 69522589 T2 DE69522589 T2 DE 69522589T2 DE 69522589 T DE69522589 T DE 69522589T DE 69522589 T DE69522589 T DE 69522589T DE 69522589 T2 DE69522589 T2 DE 69522589T2
Authority
DE
Germany
Prior art keywords
sub
vitamin
derivatives
preparation
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69522589T
Other languages
English (en)
Other versions
DE69522589D1 (de
Inventor
Masayasu Tabe
Atsuo Hazato
Kenji Manabe
Qingzhi Gao
Hiroko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE69522589D1 publication Critical patent/DE69522589D1/de
Publication of DE69522589T2 publication Critical patent/DE69522589T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69522589T 1994-06-07 1995-06-07 Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung Expired - Lifetime DE69522589T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12514494 1994-06-07
JP22018594 1994-09-14
JP22322994 1994-09-19

Publications (2)

Publication Number Publication Date
DE69522589D1 DE69522589D1 (de) 2001-10-11
DE69522589T2 true DE69522589T2 (de) 2002-04-18

Family

ID=27315056

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69521065T Expired - Lifetime DE69521065T2 (de) 1994-06-07 1995-06-07 Vitamin D3 Derivate und ein Verfahren zu ihrer Herstellung
DE69513367T Expired - Lifetime DE69513367T2 (de) 1994-06-07 1995-06-07 Vitamin d3 derivat und verfahren zu dessen herstellung
DE69522589T Expired - Lifetime DE69522589T2 (de) 1994-06-07 1995-06-07 Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69521065T Expired - Lifetime DE69521065T2 (de) 1994-06-07 1995-06-07 Vitamin D3 Derivate und ein Verfahren zu ihrer Herstellung
DE69513367T Expired - Lifetime DE69513367T2 (de) 1994-06-07 1995-06-07 Vitamin d3 derivat und verfahren zu dessen herstellung

Country Status (6)

Country Link
US (3) US5719297A (de)
EP (3) EP0854139B1 (de)
AT (3) ATE201397T1 (de)
DE (3) DE69521065T2 (de)
ES (1) ES2138212T3 (de)
WO (1) WO1995033716A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854139B1 (de) * 1994-06-07 2001-09-05 Teijin Limited Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung
DE19619036A1 (de) * 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
GB2321244B (en) * 1997-01-20 2000-11-22 Pharmacia & Upjohn Spa Vitamin D3 analogues,process for preparing them,and their use as antiproliferative and antitumour agents
US6028208A (en) * 1997-06-25 2000-02-22 Teijin Limited Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same
EP1123921A4 (de) 1998-10-23 2003-08-20 Teijin Ltd Vitamin d 3 derivate und diese enthaltende heilmittel für entzündliche erkrankungen der atemwege
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2001091794A2 (en) 2000-05-30 2001-12-06 Virginia Commonwealth University Vitamin d3 analogs as radiosensitizers for the treatment of cancer
WO2002017911A1 (fr) * 2000-08-30 2002-03-07 Teijin Limited Inhibiteurs de la production de parathormone contenant des derives de vitamine d3
AU2008202109B2 (en) * 2001-06-13 2012-02-02 Magnachem International Laboratories, Inc Lactone formulations and method of use
AU2002306150B2 (en) 2001-06-13 2008-02-14 Magnachem International Laboratories, Inc. Lactone formulations and method of use
CN1636003A (zh) * 2002-02-20 2005-07-06 帝人株式会社 维生素d3衍生物及使用其的治疗剂
EP1342796A3 (de) * 2002-02-22 2004-01-02 Teijin Limited Verbindung zur Behandlung der Paget Knochenkrankheit
JP4869597B2 (ja) 2002-11-05 2012-02-08 マグナケム インターナショナル ラボラトリーズ， インコーポレイテッド 合成ラクトン処方物ならびに使用方法
CN1771239B (zh) * 2003-01-30 2010-06-09 帝人制药株式会社 维生素d3内酯衍生物
JPWO2004067526A1 (ja) * 2003-01-31 2006-05-18 帝人ファーマ株式会社 （２３Ｓ）−１α−ヒドロキシ−２７−ノル−２５−メチレンビタミンＤ３−２６，２３−ラクトンの結晶およびその製造方法
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
EP2350645A2 (de) 2008-10-24 2011-08-03 Magnachem International Laboratories, Inc. Verfahren zur suche nach mit rad9 selektiv wechselwirkenden verbindungen
WO2010053165A1 (ja) 2008-11-04 2010-05-14 帝人ファーマ株式会社 ビタミンｄ３ラクタム誘導体
KR101666255B1 (ko) * 2013-01-08 2016-10-13 삼성에스디아이 주식회사 이차 전지

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118516A (ja) * 1981-12-29 1983-07-14 Teijin Ltd １α，２５−ジヒドロキシビタミンＤ↓３−２６，２３−ラクトンを含有するカルシユウム調節剤
JPS58210011A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS60185715A (ja) * 1984-03-05 1985-09-21 Teijin Ltd 骨形成促進剤
DE69403541T2 (de) * 1993-02-05 1997-09-25 Teijin Ltd Lacton-Verbindung und Verfahren zu ihrer Herstellung
EP0854139B1 (de) * 1994-06-07 2001-09-05 Teijin Limited Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ATE201397T1 (de) 2001-06-15
DE69521065T2 (de) 2001-10-25
ATE186721T1 (de) 1999-12-15
US6177586B1 (en) 2001-01-23
US5719297A (en) 1998-02-17
EP0854138A3 (de) 1998-09-23
ES2138212T3 (es) 2000-01-01
WO1995033716A1 (fr) 1995-12-14
EP0854138B1 (de) 2001-05-23
DE69513367T2 (de) 2000-06-08
US5986112A (en) 1999-11-16
EP0854138A2 (de) 1998-07-22
DE69521065D1 (de) 2001-06-28
EP0712843A1 (de) 1996-05-22
EP0712843A4 (de) 1996-11-13
EP0854139A2 (de) 1998-07-22
EP0854139A3 (de) 1998-09-23
DE69513367D1 (de) 1999-12-23
ATE205190T1 (de) 2001-09-15
EP0854139B1 (de) 2001-09-05
EP0712843B1 (de) 1999-11-17
DE69522589D1 (de) 2001-10-11

Similar Documents

Publication Publication Date Title
DE69522589T2 (de) Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung
DE69332577D1 (de) Verfahren zur Herstellung von 13-Ether-Derivaten von Milbemycinen und Zwischenprodukte
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
ATE42959T1 (de) Tigogenin-cellobioside und ihr hepta-azetat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die tigogenin- cellobioside enthalten.
DE69527400T2 (de) Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel
CA2053820A1 (en) Method of Inhibiting Metabolism of Cholesterol
DE69313771D1 (de) Carbazolon - Derivate und Verfahren zu ihrer Herstellung
DE3888563D1 (de) Tylosin- und 10,11,12,13-Tetrahydrotylosin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zusammensetzungen und bei deren Herstellung.
ATE9469T1 (de) Reaktive derivate des 3-oxa-bicyclo(4.3.0)-non-1- en-9-ons, verfahren zu ihrer herstellung und deren verwendung.
NZ322318A (en) Method for preparing camptothecin derivatives
ATE166060T1 (de) Neue (estradiol-derivat)-chlorambucil-konjugate, verfahren zu ihrer herstellung und pharmazeutische präparate
ATE16108T1 (de) Steroide die, in stellung 17 verestert sind, und in stellung 21 eine thioestergruppe enthalten, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
ATE199706T1 (de) Vitamin d analoga und verfahren zu ihrer herstellung
DE3884518T2 (de) Naphthothiazepin-Derivate und Verfahren zu ihrer Herstellung.
HUP0001654A2 (hu) Eljárás szubsztituált antrakinon-származékok előállítására
DE68907857D1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69302007T2 (de) Androst-4-en[4,5-b]-pyrrol-derivate und ein verfahren zu ihrer herstellung
DE3683073D1 (de) 3-oxo-2-azabicyclohexan-derivate, verfahren zu ihrer herstellung und verwendung dieser derivate als zwischenverbindungen fuer antibakterielle wirkstoffe.
DE59804539D1 (de) 15-methyl-cyclopropanosteroide und verfharen zu ihrer herstellung
DE444424T1 (de) Ungesaettigte gallsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische praeparate diese enthaltend.
DE60008300D1 (de) Oligosaccharide, Verfahren zur ihrer Herstellung und pharmazeutische Zusammensetzung die sie enthalten
SE9502876D0 (sv) New process

Legal Events

Date Code Title Description
8364 No opposition during term of opposition